Atherectomy Devices Market

Global Market Study on Atherectomy Devices: Advancements in Rotational Technology and Growing Acceptance of Peripheral Intervention Devices to Aid Steady Revenue Generation

  • January-2019
  • PMRREP3516
  • 219 Pages
  • Healthcare
  • PPT, PDF, WORD, EXCEL

Oligopolistic Market Environment with More than 90% Revenue Share of Top Five Contenders

The atherectomy devices market is primarily dominated by the leading manufactures of the oral care industry. The advanced technology associated nature of the atherectomy devices market offers lucrative business opportunities for the market players that are planning to introduce technologically advanced atherectomy devices.

Key players, such as Boston Scientific Corporation, Avinger, Inc., Cardiovascular Systems, Inc., Medtronic and Philips, account for a revenue share of more than 98% of the global atherectomy devices market. Furthermore, increasing partnerships between the key players operating in the atherectomy devices market and international distributors is estimated to boost the penetration of atherectomy devices.

The increasing demand from developed regions has resulted in the concentration of the atherectomy devices in these regions. The U.S. is a major regional market and accounts for a large number of atherectomy procedures.

Key players in the atherectomy devices market, such as Cardiovascular Systems Inc., have a major hold on the U.S. market. The company has a major presence in the U.S. alone, and generates approximately US$ 188.00 million worth of revenue through the sales of orbital atherectomy systems. Moreover, the company holds a monopoly in the orbital atherectomy segment.

Key players in the atherectomy products market offer a large portfolio of products in developed regions. The demand in developed regions is fuelled by the growing awareness about atherectomy procedures and Peripheral Artery Diseases (PADs).

Find Out More about the Report Coverage

Companies

Company Profiles

  • Medtronic Plc.
  • Boston Scientific Corporation
  • Cardiovascular Systems, Inc.
  • Avinger, Inc.
  • Koninklijke Philips N.V. (Spectranetics + Volcano)
  • Others.

Strategic Mergers and Acquisitions in the Atherectomy Devices Market is Creating a Highly Competitive Scenario

With reference to the growth trend of the medical device market, partnerships & mergers are among the key trends witnessed in the atherectomy device market in the recent years. Large companies are entering the atherectomy devices market by strategically expanding their reach through acquisitions and mergers, which is a promising trend that has arisen as a result of the substantial demand for atherectomy.

The bundling of atherectomy devices at discounted rates and supply contracts is leading to a decline in ASPs, which has hampered the growth of Drug Coated Balloon (DCB) catheters. These catheters have experienced steady cost declines in the recent years. In contrast to these market changes, another significant factor affecting the atherectomy market is the exit and entrance of co-participating companies

  • Avinger – a leading startup in the atherectomy devices – has entered the market with the adoption of new imaging technology-integrating Ocular Coherence Tomography (OCT) in its Pantheris product
  • On 2nd September 2014, Boston Scientific acquired the Interventional business segment from BAYER to expand its peripheral interventions division
  • In 2015, the leading medical devices company Medtronic acquired Covidien. Prior to its acquisition, Covidien acquired the atherectomy devices company ev3 in 2010
  • In February, 2015, PHILIPS –– acquired VOLCANO Corporation to boost its share in the atherectomy and peripheral vascular intervention segment as well as to expand its image-guided therapy business
    • In June 2017, Philips acquired the Spectranetics Corporation to expand its presence in the image-guided therapy business segment

Customize this Report

Explore Intelligence Tailored to Your Business Goals.

Large Target Patient Pool Suffering from Arthrosclerosis, Diabetes and Obesity

There has been a noticeable rise in the number of patients suffering from arthrosclerosis, diabetes and obesity. The number of patients undergoing angioplasty, interventions and catheterisation for reducing Arterial Plaque (AP) has been on a consistent rise.

Hence, the presence of a large target patient pool suffering from Peripheral Artery Diseases (PAD) and patients that require central vascular access in ICUs, outpatients, CathLabs and operation theatres is projected to present numerous growth opportunities for manufacturers in the global atherectomy devices market.

Critical limb ischemia was the leading cause of amputation in the U.S. in 2016, wherein an estimated 4,300,000 people in the country had critical limb ischemia and a part of this population was also diagnosed with PAD. The increasing number of patients suffering from gangrene is also estimated to boost the need for atherectomy devices worldwide.

Market Research Methodology - Perfected through Years of Diligence

A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.

Get actionable insights on Ship Repair And Maintenance Services Market

Increasing Usage of Drug-Coated Balloons (DCB) in Atherectomy Procedures

Growth in the volume of DAART procedures is expected to drive the unit sales of atherectomy devices over the study period. In July 2015, the U.S. Centers for Medicare & Medicaid Services (CMS) upgraded the pass-through compensation for Drug-Coated Balloons (DCBs). This is expected to drive the usage of DCBs in office-based labs and outpatient settings, and will contribute directly to growth in the volume of procedures that utilise atherectomy devices.

The extensive outcomes from the one-year DEFINITIVE AR research study have established that a combination of directional atherectomy with anti-restenosis therapy (DAART) with drug-coated balloons increases patency in long lesions and lesions with severe calcifications.

The availability of combination devices is not only limited to rotational atherectomy devices, but also other atherectomy devices. For instance, orbital and directional devices are also utilized during procedures that involve plaque modification stent placement.

Explore Persistence Market Research’s expertise in promulgation of the business !

Growing Incidence of Peripheral Artery Diseases (PADs) and Coronary Artery Diseases (CADs)

Increasing demand for vascular and coronary intervention owing to increasing cases of Peripheral Artery Diseases (PADs) and Coronary Artery Diseases (CADs) in the recent years is expected to drive the atherectomy devices market in the near future. Cases of diabetes, critical limb ischemia and cardiovascular diseases have increased in the recent past, even among younger patients.

The increasing incidence of vascular diseases and disorders related to or caused by calcified peripheral and coronary artery, reduced blood flow and lower-limb amputation are estimated to fuel the demand for atherectomy devices over the forecast period and simultaneously projected to increase at a robust rate over the coming years.

atherectomy devices market

Competitive Landscape

The competition section of the atherectomy devices market features the profiles of the key players operating in the market based on their shares, differential strategies, product offerings, marketing approach and company dashboard. Some of the key players operating in the atherectomy devices market include Boston Scientific Corporation, Avinger, Inc., Cardiovascular Systems, Inc., Medtronic and Royal Philips.

Definition

Atherectomy devices are minimally invasive devices intend for the use in peripheral vascular intervention procedures. The principle of atherectomy is based on gaining substantial lumen in re-establishing the blood flow in the arteries by removing plaque and calcified lesions from the artery.

About the Report

PMR has conducted a research study on the atherectomy devices market for the forecast period 2018 to 2026. The atherectomy devices market report offers a comprehensive evaluation of the business opportunities available in the atherectomy devices market, along with insights on the consumption of atherectomy devices, incidence of diseases, awareness about critical limb ischemia and the competitive landscape of the atherectomy devices market.

The report elaborates on the macro-economic factors influencing the dynamics of the atherectomy devices market and its futuristic potential.

Segmentation

The report offers a comprehensive taxonomy of the atherectomy devices market based on the device type, indication, end user and region. The different atherectomy devices in the market include rotational atherectomy devices, directional atherectomy devices, orbital atherectomy devices and laser ablation atherectomy devices.

These atherectomy devices are utilised is indications such as coronary artery diseases and peripheral artery diseases. Atherectomy devices are intended for end users such as hospitals, ambulatory surgical centres and Office-Based Labs (OBL). The atherectomy devices market has been analysed across the regions of North America, Latin America, Europe, Asia Pacific and MEA.

Additional Questions Answered

Some of the additional questions addressed in the atherectomy devices market report are:

  • What is the revenue potential of atherectomy devices across the regions of North America and Europe?
  • Who are the key competitors and what are their portfolios in atherectomy devices market?
  • What are major challenges influencing the growth of the atherectomy devices market?
  • How is intervention from regulatory authorities impacting the growth of the atherectomy devices market?

Research Methodology

The atherectomy devices market has been estimated based on the supply-demand approach. The market was first calculated based on the consumption of atherectomy devices in different regions/countries. The volume growth of atherectomy devices was estimated based on the consumption of various types of atherectomy devices in the top 20 countries globally across five disease indications.

Other qualitative factors analysed during the volume estimation of atherectomy devices include the level of awareness regarding Peripheral Artery Disease (PAD) and others. This information is further validated with rigorous primary research (which includes interviews, surveys, in-person interactions and the viewpoints of seasoned analysts) and secondary research (including verified paid sources, authentic trade journals and resourceful databases).

The research study on the atherectomy devices market also includes the top trends and macro- as well as micro-economic factors shaping the atherectomy devices market. With this approach, the report on the atherectomy devices market estimates the industry attractiveness of every major segment of the atherectomy devices market over the forecast period.

Media Release

Our Clients

Our Clients